A novel application of melting curves: Utility of peak area calculation for relative methylation quantification

Clinical Chemistry and Laboratory Medicine

Volumn 45, Issue 7, 2007, Pages 867-873

  Deligezer, Ugur ^a   Esin Akisik, Ebru ^a   Dalay, Nejat ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Oncology Institute   (Turkey)

Author keywords

Leukemia; Melting curve; Methylation; Methylation index; Peak area calculation

Indexed keywords

BISULFITE;

AREA UNDER THE CURVE; ARTICLE; BONE MARROW; CALCULATION; CONTROLLED STUDY; DNA METHYLATION; DNA TEMPLATE; GENE AMPLIFICATION; GENE SEQUENCE; GENE TRANSLOCATION; HUMAN; MELTING POINT; MONONUCLEAR CELL; NORMAL DISTRIBUTION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; DNA METHYLATION; FEMALE; GENES, P16; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TRANSITION TEMPERATURE; TUMOR MARKERS, BIOLOGICAL;

EID: 34447289610     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2007.146     Document Type: Article

References (40)

1. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005;2(Suppl 1):S4-11.
2. Gopisetty G, Ramachandran K, Singal R. DNA methylation and apoptosis. Mol Immunol 2006;43:1729-40.
3. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002;196:1-7.
4. Esteller M. Relevance of DNA methylation in the management of cancer. Lancet Oncol 2003;4:351-8.
5. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003;3:253-66.
6. Widschwendter M, Siegmund KD, Muller HM, Fiegl H, Marth C, Muller-Holzner E, et al. Association of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifen. Cancer Res 2004;64:3807-13.
7. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005;352:997-1003.
8. Muller HM, Millinger S, Fiegl H, Goebel G, Ivarsson L, Widschwendter A, et al. Analysis of methylated genes in peritoneal fluids of ovarian cancer patients: a new prognostic tool. Clin Chem 2004;50:2171-3.
9. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005;97:1330-8.
10. Giovannucci E, Ogino S. DNA methylation, field effects, and colorectal cancer. J Natl Cancer Inst 2005;97:1317-9.
11. Woodson K, Weisenberger DJ, Campan M, Laird PW, Tangrea J, Johnson LL, et al. Gene-specific methylation and subsequent risk of colorectal adenomas among participants of the polyp prevention trial. Cancer Epidemiol Biomarkers Prev 2005;14:1219-23.
12. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992;89:1827-31.
13. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-6.
14. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-4.
15. Gonzalgo ML, Jones PA. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SNuPE). Nucleic Acids Res 1997;25:2529-31.
16. Bianco T, Hussey D, Dobrovic A. Methylation-sensitive, single-strand conformation analysis (MS-SSCA): a rapid method to screen for and analyze methylation. Hum Mutat 1999;14:289-93.
17. Eads CA, Danenberg KD, Kawakami K, Kawakami K, Saltz LB, Blake C, et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000;28:e32.
18. El-Maarri O, Herbiniaux U, Walter J, Oldenburg J. A rapid, quantitative, non-radioactive bisulfite-SNuPE- IP RP HPLC assay for methylation analysis at specific CpG sites. Nucleic Acids Res 2002;30:e25.
19. Deng D, Deng G, Smith MF, Zhou J, Xin H, Powell SM, et al. Simultaneous detection of CpG methylation and single nucleotide polymorphism by denaturing high performance liquid chromatography. Nucleic Acids Res 2002;30:e13.
20. Gitan RS, Shi H, Chen CM, Yan PS, Huang TH. Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res 2002;12:158-64.
21. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002;30:e57.
22. Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques 2003;35:152-6.
23. Cottrell SE, Distler J, Goodman NS, Mooney SH, Kluth A, Olek A, et al. A real-time PCR assay for DNA-methylation using methylation-specific blockers. Nucleic Acids Res 2004;32:e10.
24. Brena RM, Auer H, Kornacker K, Hackanson B, Raval A, Byrd JC, et al. Accurate quantification of DNA methylation using combined bisulfite restriction analysis coupled with the Agilent 2100 Bioanalyzer platform. Nucleic Acids Res 2006;34:e17.
25. Worm J, Aggerholm A, Guldberg P. In-tube DNA methylation profiling by fluorescence melting curve analysis. Clin Chem 2007;47:1183-9.
26. Akey DT, Akey JM, Zhang K, Jin L. Assaying DNA methylation based on high-throughput melting curve approaches. Genomics 2002;80:376-84.
27. Deligezer U, Erten N, Akisik EE, Dalay N. Methylation of the INK4A/ARF locus in blood mononuclear cells. Ann Hematol 2006;85:102-7.
28. Marras SA, Tyagi S, Kramer FR. Real-time assays with molecular beacons and other fluorescent nucleic acid hybridization probes. Clin Chim Acta 2006;363:48-60.
29. Houghton, SG, Cockerill FR. Real-time PCR: overview and applications. Surgery 2006;139:1-5.
30. Zheng S, Chen P, McMillan A, Lafuente A, Lafuente MJ, Ballesta A, et al. Correlations of partial and extensive methylation at the p14 (ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors. Carcinogenesis 2000;21:2057-64.
31. Chen H, Wu S. Hypermethylation of the p15 (INK4B) gene in acute leukemia and myelodysplastic syndromes. Chin Med J 2002;115:987-90.
32. Nomoto K, Maekawa M, Sugano K, Ushiama M, Fukayama N, Fujita S, et al. Methylation status and expression of human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP. Jpn J Clin Oncol 2002;32:3-8.
33. Yu J, Leung WK, Ebert MP, Leong RW, Tse PC, Chan MW, et al. Absence of cyclin D2 expression is associated with promoter hypermethylation in gastric cancer. Br J Cancer 2003;88:1560-5.
34. Graziano F, Arduini F, Ruzzo A, Bearzi I, Humar B, More H, et al. Prognostic analysis of E-cadherin gene promoter hypermethylation in patients with surgically resected, node-positive, diffuse gastric cancer. Clin Cancer Res 2004;10:2784-9.
35. Sidiropoulos M, Pampalakis G, Sotiropoulou G, Katsaros D, Diamandis EP. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers. Tumour Biol 2005;26:324-36.
36. Herman JG, Civin CI, Issa JP, Collector MI, Sharkis SJ, Baylin SB. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res 1997;57:837-41.
37. Melki JR, Vincent PC, Clark SJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999;59:3730-40.
38. Chim CS, Liang R, Tam CY, Kwong YL. Methylation of p15 and p16 genes in acute promyelocytic leukemia: potential diagnostic and prognostic significance. J Clin Oncol 2001;19:2033-40.
39. Nagy E, Beck Z, Kiss A, Csoma E, Telek B, Konya J, et al. Frequent methylation of p16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase. Eur J Cancer 2003;39:2298-305.
40. Kusy S, Cividin M, Sorel N, Brizard F, Guilhot F, Brizard A, et al. p14ARF, p15INK4b, and p16INK4a methylation status in chronic myelogenous leukemia. Blood 2003;101:374-5.